Article
Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients.
Molecular biology reports - 1 Jan 2015
Sharaki Ola, Zeid Montasser, Moez Pacint, Zakaria Nermine Hossam, Nassar Eman
Abstract excerpt
Advances in immunosuppressive therapy allowed renal transplantation to become the treatment of choice for suitable candidates with (end stage renal disease) ESRD. The post-transplant therapeutic strategy is difficult due to narrow therapeutic indices for the currently used immunosuppressive drugs. Inter-individual differences in drug bioavailability are related to genetic and non genetic factors. The idea of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
